Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viking Therapeutics, Inc. | 434,890 | reported | 05 Jan 2026 | tx 97+1,949,604−1,418,994 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 41,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 32,049 | 0.00 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 31,961 | 32.29 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 13,600 | 33.37 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 10,500 | 34.22 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 1,600 | 35.07 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 91,000 | 0.00 USD | deriv |
| 27 Oct 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 11,117 | 0.00 USD | |
| 28 Oct 2025 | SALE | Viking Therapeutics, Inc. | 6,185 | 35.00 USD | |
| 02 Jul 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 7,667 | 0.00 USD | |
| 03 Jul 2025 | SALE | Viking Therapeutics, Inc. | 4,266 | 27.77 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 21,667 | 0.00 USD | |
| 06 Jan 2025 | SALE | Viking Therapeutics, Inc. | 49,115 | 42.69 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 44,533 | 0.00 USD | |
| 06 Jan 2025 | SALE | Viking Therapeutics, Inc. | 5,100 | 43.32 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 37,200 | 0.00 USD | deriv |
| 29 Jul 2024 | GRANT_AWARD | Viking Therapeutics, Inc. | 10,000 | 0.00 USD | |
| 30 Jul 2024 | SALE | Viking Therapeutics, Inc. | 14,704 | 56.98 USD | |
| 30 Jul 2024 | SALE | Viking Therapeutics, Inc. | 3,322 | 57.82 USD | |
| 29 Jul 2024 | GRANT_AWARD | Viking Therapeutics, Inc. | 21,667 | 0.00 USD | |
| 01 May 2024 | EXERCISE | Viking Therapeutics, Inc. | 35,426 | 7.77 USD | |
| 01 May 2024 | EXERCISE | Viking Therapeutics, Inc. | 51,000 | 8.52 USD | |
| 01 May 2024 | SALE | Viking Therapeutics, Inc. | 23,746 | 76.40 USD | |
| 01 May 2024 | SALE | Viking Therapeutics, Inc. | 26,142 | 77.49 USD | |
| 01 May 2024 | SALE | Viking Therapeutics, Inc. | 105,343 | 78.65 USD |